Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

NIMBLE Study

A 52-Week Study to Compare a New Drug (GSK3511294) with Mepolizumab or Benralizumab in Adolescents with Severe Asthma

physician listening to girl's heart

 

AGE: 12+ years old
SEX AT BIRTH: All
TYPE: Interventional Treatment Study
HEALTHY PARTICIPANTS: No
CONDITION: Asthma
LOCATION: University Hospitals Cleveland Medical Center

Learn More About This Research Study

For more information, please contact study coordinator, Emily Witte at 216-286-6274 and leave a message or complete the online form below.

Study Purpose

The purpose of this study is to compare the investigational study drug, GSK3511294 with either mepolizumab or benralizumab for the treatment of asthma.

Who Can Participate

Participants with severe asthma that has been controlled with mepolizumab or benralizumab may be eligible for this study.

I'm not a robot

Study ID